The paper published in eBioMedicine describes how the scientists identified the four distinct sequential pathways by analyzing longitudinal health data from close to 25,000 patients and validated their findings in the nationally diverse All of Us Research Program.
Rather than focusing on individual risk factors, this study mapped sequential diagnostic patterns that reveal how conditions progress towards Alzheimer’s disease (AD). Their findings offer new insight as to how the debilitating brain-wasting disease develops over time rather than from isolated risk factors.
“We found that multi-step trajectories can indicate greater risk factors for Alzheimer’s disease than single conditions,” said first author Mingzhou Fu, a medical informatics pre-doctoral student at the University of California – Los Angeles Health Sciences (UCLA). “Understanding these pathways could fundamentally change how we approach early detection and prevention.”
The four major trajectory clusters with distinct demographical and clinical characteristics identified were:
- Mental health pathway: Psychiatric conditions leading to cognitive decline
- Encephalopathy pathway: Brain dysfunction conditions that escalate over time
- Mild cognitive impairment pathway: Gradual cognitive decline progression
- Vascular disease pathway: Cardiovascular conditions that contribute to dementia risk
According to the scientists, approximately 26% of diagnostic progressions showed consistent directional ordering. For example, hypertension often preceded depressive episodes, which then increased Alzheimer’s risk.
“Recognizing these sequential patterns rather than focusing on diagnoses in isolation may help clinicians improve Alzheimer’s disease diagnosis,” said lead author Dr. Timothy Chang, assistant professor in Neurology at UCLA Health.
For this study, data was collected and analyzed from 5,762 patients who contributed 6,791 unique Alzheimer’s progression trajectories. Computational methods, including machine learning clustering, network analysis, and dynamic time warping, were used to map the temporal relationships between diagnosis leading to Alzheimer’s disease.
Validation in the All of Us Research Program confirmed that the trajectory patterns apply across different populations and demographics. Validation in an independent population revealed these trajectories predicted AD risk more accurately than single diagnoses alone, which could be used for:
- Enhanced risk stratification: Identifying high-risk patients earlier in disease progression
- Targeted interventions: Interrupting harmful sequences before they advance
- Personalized prevention: Tailoring strategies based on individual pathway patterns
Alzheimer’s Disease Global Impact
These findings inspire hope around the World, including the more than 6.7 million Americans who are living with Alzheimer’s disease, and this number is expected to increase to over 14 million by 2060.
In the UK, approximately 982,000 people are currently living with dementia. It is estimated that around two-thirds of these individuals have Alzheimer’s disease. This means that roughly 650,000 people in the UK are living with Alzheimer’s disease. This number is projected to rise to 1.4 million by 2040, according to the Alzheimer’s Society.
Globally, recent estimates are that over 55 million people are living with Alzheimer’s disease or other forms of dementia; this number is also projected to significantly increase to reach at least 139 million by 2050.
While pinpointing exact rankings is complex, available data suggests that countries in Western Europe and North America tend to have some of the highest rates of Alzheimer’s disease, with Finland notably having a high dementia mortality rate.
Additionally, the Eastern and Southeastern regions of the United States also show high prevalence. However, the global burden is shifting, with the majority of future increases expected in low and middle-income countries, particularly in Asia.
Western Europe
Countries like Finland, the UK, and Iceland have high rates of Alzheimer’s and dementia. For example, Finland has a particularly high mortality rate from dementia.
North America
The US also has a significant prevalence of Alzheimer’s, with some areas like the east and southeast showing higher rates.
Other regions
While rates might be lower in some regions, like Sub-Saharan Africa, the sheer population growth in countries like India and China will lead to a substantial increase in the absolute number of people with dementia in these areas.
Global shift
A significant portion of the future increase in dementia cases is projected to occur in low and middle-income countries.
Several factors are thought to have contributed to these variations, including differences in access to healthcare, lifestyle factors, genetic predispositions, and environmental exposures. This study suggests that there is more to it than what was once thought.
As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before changing your wellness routine. WHN does not agree or disagree with any of the materials posted. This article is not intended to provide a medical diagnosis, recommendation, treatment, or endorsement. Additionally, it is not intended to malign any religion, ethnic group, club, organization, company, individual, or anyone or anything. These statements have not been evaluated by the Food and Drug Administration.
